TrialNeuropsychiatric disease and treatment2020

Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies.

Sharon B Wigal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.